This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

China's block of Meta-Manus deal underscores higher bar for cross-border tech deals

By MLex Staff ( April 29, 2026, 08:09 GMT | Comment) -- China's landmark decision to block Meta Platforms' acquisition of artificial intelligence startup Manus underscores Beijing's evolving approach to evaluating cross-border technology deals, with authorities now explicitly tying AI and technical talent to national security imperatives. The move represents one of the most significant uses yet of Beijing's expanding toolkit for controlling such flows, and appears to be the first proactively disclosed case in which a deal was both blocked and ordered unwound since the implementation of China’s 2021 foreign investment security review rules.China's landmark decision to block Meta Platforms' acquisition of artificial intelligence startup Manus highlights Beijing's evolving approach to evaluating cross-border technology deals, with authorities now explicitly tying AI and technical talent to national security imperatives....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login